Ertapenem Injection, Powder, Lyophilized, For Solution
Product Images NDC 68083-351

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ertapenem (NDC 68083-351). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ertapenem Spl Carton Label

Ertapenem Spl Carton Label
This appears to be a description of a pharmaceutical product called "Ertapenem for Injection". The information provided contains the NDC number, manufacturer name, and instructions on how to use the product. However, there is not enough information to provide a more detailed description or indication of what the product is used for.*
FDA Label Image

Ertapenem Spl Container Label

Ertapenem Spl Container Label
This is a description of a single dose vial with National Drug Code (NDC) 68083-351-01. The vial contains 1.046 grams of ertapenem sodium for intravenous or intramuscular use. Inactive ingredients include sodium bicarbonate and sodium hydroxide to adjust the pH. The color of the solution ranges from colorless to pale yellow, but variations within this range don't impact potency. There are accompanying instructions for product reconstitution, dilution, and dosage in the Prescribing Information. The vial shouldn't be stored above 25°C. The manufacturer is Gland Pharma Limited in Hyderabad, India.*
FDA Label Image

Ertapenem Spl Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.